Healthcare Integrated Technologies, Inc.
Healthcare Integrated Technologies, Inc. (HITC) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Healthcare Integrated Technologies, Inc. (HITC), covering cash flow, earnings, and balance sheets.
Healthcare Integrated Technologies, Inc. (HITC) Income Statement & Financial Overview
View the income breakdown for Healthcare Integrated Technologies, Inc. HITC across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $239948.00 | $60283.00 | $21769.00 |
| Cost of Revenue | $0.00 | $167091.00 | $55697.00 | $55697.00 |
| Gross Profit | $0.00 | $72857.00 | $4586.00 | -$33928.00 |
| Gross Profit Ratio | $0.00 | $0.30 | $0.08 | -$1.56 |
| R&D Expenses | $0.00 | $15287.00 | $7006.00 | $4381.00 |
| SG&A Expenses | $343787.00 | $202973.00 | $206443.00 | $108030.00 |
| Operating Expenses | $670201.00 | $664037.00 | $206443.00 | $108030.00 |
| Total Costs & Expenses | $670201.00 | $664037.00 | $262139.00 | $163727.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $13937.00 | $15669.00 | $13361.00 | $13205.00 |
| Depreciation & Amortization | $54354.00 | $54828.00 | $55697.00 | $55697.00 |
| EBITDA | -$615847.00 | -$33108.00 | -$146160.00 | -$86261.00 |
| EBITDA Ratio | $0.00 | -$0.14 | -$2.42 | -$3.96 |
| Operating Income | -$670201.00 | -$424089.00 | -$201860.00 | -$141960.00 |
| Operating Income Ratio | $0.00 | -$1.77 | -$3.35 | -$6.52 |
| Other Income/Expenses (Net) | -$13937.00 | $320484.00 | -$13361.00 | -$13205.00 |
| Income Before Tax | -$684138.00 | -$103605.00 | -$215218.00 | -$155163.00 |
| Income Before Tax Ratio | $0.00 | -$0.43 | -$3.57 | -$7.13 |
| Income Tax Expense | $0.00 | $0.00 | $3.00 | $3.00 |
| Net Income | -$684138.00 | -$103605.00 | -$215218.00 | -$155163.00 |
| Net Income Ratio | $0.00 | -$0.43 | -$3.57 | -$7.13 |
| EPS | -$0.008 | -$0.002 | -$0.003 | -$0.002 |
| Diluted EPS | -$0.008 | -$0.002 | -$0.003 | -$0.002 |
| Weighted Avg Shares Outstanding | $83.44M | $70.05M | $71.48M | $69.41M |
| Weighted Avg Shares Outstanding (Diluted) | $83.44M | $70.05M | $71.48M | $69.41M |
Over the last four quarters, Healthcare Integrated Technologies, Inc.'s revenue moved from $21769.00 in Q2 2024 to $0.00 in Q1 2025. Operating income in Q1 2025 was -$670201.00, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for Healthcare Integrated Technologies, Inc. remained robust at -$615847.00, reflecting operational efficiency. Net income dropped to -$684138.00, with an EPS of -$0.008. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan